NO20051561D0 - Vaksine - Google Patents

Vaksine

Info

Publication number
NO20051561D0
NO20051561D0 NO20051561A NO20051561A NO20051561D0 NO 20051561 D0 NO20051561 D0 NO 20051561D0 NO 20051561 A NO20051561 A NO 20051561A NO 20051561 A NO20051561 A NO 20051561A NO 20051561 D0 NO20051561 D0 NO 20051561D0
Authority
NO
Norway
Prior art keywords
vaccine
Prior art date
Application number
NO20051561A
Other languages
English (en)
Other versions
NO20051561L (no
Inventor
Gerald Wayne Gough
Christopher Michael Roberts
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20051561D0 publication Critical patent/NO20051561D0/no
Publication of NO20051561L publication Critical patent/NO20051561L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20051561A 2002-10-03 2005-03-23 Nukleinsyremolekyler som koder for humant papillomavirus og anvendelse av disse i vaksine. NO20051561L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0222953.2A GB0222953D0 (en) 2002-10-03 2002-10-03 Novel Compounds
PCT/EP2003/011158 WO2004031222A2 (en) 2002-10-03 2003-10-01 Dna vaccine encoding at least two nonstructural early proteins of papillomavirus

Publications (2)

Publication Number Publication Date
NO20051561D0 true NO20051561D0 (no) 2005-03-23
NO20051561L NO20051561L (no) 2005-06-02

Family

ID=9945247

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051561A NO20051561L (no) 2002-10-03 2005-03-23 Nukleinsyremolekyler som koder for humant papillomavirus og anvendelse av disse i vaksine.

Country Status (21)

Country Link
US (2) US20060165713A1 (no)
EP (1) EP1546191A2 (no)
JP (1) JP2006516386A (no)
KR (1) KR20050050115A (no)
CN (1) CN100393878C (no)
AR (1) AR041515A1 (no)
AU (1) AU2003294672A1 (no)
BR (1) BR0314986A (no)
CA (1) CA2500093A1 (no)
CO (1) CO5580837A2 (no)
GB (1) GB0222953D0 (no)
IS (1) IS7775A (no)
MA (1) MA27474A1 (no)
MX (1) MXPA05003558A (no)
NO (1) NO20051561L (no)
NZ (1) NZ539154A (no)
PL (1) PL376534A1 (no)
RU (1) RU2354701C2 (no)
TW (1) TW200411055A (no)
WO (1) WO2004031222A2 (no)
ZA (1) ZA200503201B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1556077A2 (en) 2002-10-29 2005-07-27 Coley Pharmaceutical Group, Ltd Use of cpg oligonucleotides in the treatment of hepatitis c virus infection
CN101617052A (zh) * 2007-01-30 2009-12-30 特兰斯吉恩股份有限公司 用于免疫的***瘤病毒e2多肽
GB0710538D0 (en) * 2007-06-01 2007-07-11 Glaxo Group Ltd Vaccine
EP2585107B1 (en) 2010-06-25 2018-10-24 Vaccibody AS Homodimeric protein constructs
MY195018A (en) * 2014-10-24 2023-01-03 Hpvvax Llc Cancer and skin lesion treatment
US20190134190A1 (en) * 2016-05-04 2019-05-09 Transgene Sa Combination therapy with cpg tlr9 ligand

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN443995A0 (en) * 1995-07-27 1995-08-17 Csl Limited Papillomavirus polyprotein
WO2002008435A1 (en) * 2000-07-21 2002-01-31 Glaxo Group Limited Codon-optimized papilloma virus sequences
GB0017990D0 (en) * 2000-07-21 2000-09-13 Glaxo Group Ltd Papilloma virus sequences

Also Published As

Publication number Publication date
RU2354701C2 (ru) 2009-05-10
CO5580837A2 (es) 2005-11-30
AU2003294672A1 (en) 2004-04-23
GB0222953D0 (en) 2002-11-13
JP2006516386A (ja) 2006-07-06
AR041515A1 (es) 2005-05-18
PL376534A1 (pl) 2006-01-09
MXPA05003558A (es) 2005-06-03
CA2500093A1 (en) 2004-04-15
RU2005109155A (ru) 2006-03-10
KR20050050115A (ko) 2005-05-27
CN100393878C (zh) 2008-06-11
NO20051561L (no) 2005-06-02
BR0314986A (pt) 2005-08-09
US20070264283A1 (en) 2007-11-15
CN1720261A (zh) 2006-01-11
WO2004031222A3 (en) 2004-08-19
TW200411055A (en) 2004-07-01
EP1546191A2 (en) 2005-06-29
MA27474A1 (fr) 2005-08-01
ZA200503201B (en) 2006-06-28
WO2004031222A2 (en) 2004-04-15
NZ539154A (en) 2007-05-31
IS7775A (is) 2005-03-29
US20060165713A1 (en) 2006-07-27

Similar Documents

Publication Publication Date Title
IS7831A (is) Bóluefni
NO20050132D0 (no) Vaksinesammensetning
IS7547A (is) Ónæmisvaldandi samsetningar
ATE457980T1 (de) Aryloxime
ATE318817T1 (de) Aza-arylpiperazine
ATE427876T1 (de) Luftkissenboot
DE50212360D1 (de) Anfahrhilfesteuerungsvorrichtung
DE50212349D1 (de) Hirurgie
DK1427444T3 (da) West-nil-vaccine
DE60323981D1 (de) Zimtsäureamidderivate
NO20033882L (no) Vaksine
ATE349458T1 (de) Etonogestrelester
IS2922B (is) Bóluefni
DE60328408D1 (de) Impfstoff
ATA1572002A (de) Managementspleisskassette
NO20051561D0 (no) Vaksine
ATA4142004A (de) Trägerverbau
ATA19152002A (de) Hubkupplung
ATE396192T1 (de) N-sulfonylaminothiazole
DE60320425D1 (de) Ostertagia-impfstoff
DE50300322D1 (de) Zylinderkopfdichtung
DE10244834B8 (de) Suszeptometer
DE50209283D1 (de) Tropfbewässerungsrohr
ATA16872002A (de) Zwischenstück
DE10211707A8 (de) Segmentstatormaschine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application